Zhongmu Group and Huisheng Biotech signed a strategic cooperation agreement.

According to Hui Sheng Biology, on July 9, 2026, Li Yin, Chairman of Zhongmu Stock, Jiao Jie, Vice General Manager, and Zhu Guangshan, Assistant General Manager, visited Hui Sheng Biology for inspection and exchange, and signed a strategic cooperation agreement. Both parties will give full play to their advantages in resources, technology, and market, achieve complementary advantages, share risks, and benefits, and jointly promote technological innovation and industrial upgrading in the animal medicine industry.